Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT04774939
NA
EVLA and Optimal Timing of Sclerotherapy
Sponsor: Turku University Hospital
View on ClinicalTrials.gov
Summary
The aim of the study is to investigate the optimal timing of sclerotherapy for treatment of varicose tributaries on EVLA (endogenous laser ablation) patients.
Official title: FinnTrunk, EVLA and Optimal Timing of Sclerotherapy
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
350
Start Date
2021-03-15
Completion Date
2030-03-15
Last Updated
2021-03-01
Healthy Volunteers
No
Conditions
Interventions
PROCEDURE
Endovenous laser ablation
The aim is to combine the significance of for sclerotherapy at the primary EVLA treatment
Locations (1)
Turku University Hospital
Turku, Finland